{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:25:43Z","timestamp":1793247943635,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Ageing Research Reviews"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/j.arr.2024.102203","type":"journal-article","created":{"date-parts":[[2024,1,20]],"date-time":"2024-01-20T11:25:30Z","timestamp":1705749930000},"page":"102203","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"special_numbering":"C","title":["Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis"],"prefix":"10.1016","volume":"94","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0662-5637","authenticated-orcid":false,"given":"Itsuki","family":"Terao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wakako","family":"Kodama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.arr.2024.102203_bib1","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1111\/ene.15007","article-title":"Brain volume loss due to donanemab","volume":"28","author":"Ayton","year":"2021","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2024.102203_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.14283\/jpad.2022.30","article-title":"Two randomized phase 3 studies of Aducanumab in early Alzheimer's disease","volume":"9","author":"Budd Haeberlein","year":"2022","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102203_bib3","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/s41582-023-00883-2","article-title":"Tau-targeting therapies for Alzheimer disease: current status and future directions","volume":"19","author":"Congdon","year":"2023","journal-title":"Nat. Rev. Neurol."},{"key":"10.1016\/j.arr.2024.102203_bib4","first-page":"46","article-title":"Revisiting global cognitive and functional state 13 years after a clinical trial of lithium for mild cognitive impairment","volume":"45","author":"Damiano","year":"2023","journal-title":"Rev. Bras. De. Psiquiatr."},{"key":"10.1016\/j.arr.2024.102203_bib5","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1002\/jrsm.1195","article-title":"GetReal in network meta-analysis: a review of the methodology","volume":"7","author":"Efthimiou","year":"2016","journal-title":"Res Synth. Methods"},{"key":"10.1016\/j.arr.2024.102203_bib6","unstructured":"Eisai, 2021. Biogen announces reduced price for Aduhelm\u00ae to improve access for patients with early alzheimer\u2019s disease in the United States. \u3008https:\/\/www.eisai.com\/news\/2021\/news2021100.html\u3009 (Accessed 25 March, 2021)."},{"key":"10.1016\/j.arr.2024.102203_bib7","unstructured":"Eisai, 2023. EISAI\u2019S approach to U.S. pricing for Leqembi\u2122 (LECANEMAB), a treatment for early Alzheimer\u2019s disease, sets forth our concept of \u201csocietal value of medicine\u201d in relation to \u201cprice of medicine\u201d. \u3008https:\/\/www.eisai.com\/news\/2023\/news202302.html\u3009 (Accessed 25 March, 2023)."},{"key":"10.1016\/j.arr.2024.102203_bib8","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1002\/gps.4730","article-title":"Amyloid is essential but insufficient for Alzheimer causation: addition of subcellular cofactors is required for dementia","volume":"33","author":"Fessel","year":"2018","journal-title":"Int J. Geriatr. Psychiatry"},{"key":"10.1016\/j.arr.2024.102203_bib9","article-title":"Alzheimer's disease and inflammatory biomarkers positively correlate in plasma in the UK-ADRC cohort","author":"Foley","year":"2023","journal-title":"Alzheimers Dement"},{"key":"10.1016\/j.arr.2024.102203_bib10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1192\/bjp.2019.76","article-title":"Clinical and biological effects of long-term lithium treatment in older adults with amnestic mild cognitive impairment: randomised clinical trial","volume":"215","author":"Forlenza","year":"2019","journal-title":"Br. J. Psychiatry"},{"key":"10.1016\/j.arr.2024.102203_bib11","doi-asserted-by":"crossref","DOI":"10.1186\/s40035-022-00279-0","article-title":"Brain-derived neurotrophic factor in Alzheimer's disease and its pharmaceutical potential","volume":"11","author":"Gao","year":"2022","journal-title":"Transl. Neurodegener."},{"key":"10.1016\/j.arr.2024.102203_bib12","doi-asserted-by":"crossref","first-page":"473","DOI":"10.3233\/JAD-230568","article-title":"Lithium, a treatment option for Alzheimer's disease? A review of existing evidence and discussion on future perspectives","volume":"96","author":"Guilliot","year":"2023","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102203_bib13","doi-asserted-by":"crossref","first-page":"4414","DOI":"10.1093\/brain\/awad188","article-title":"Amyloid-related imaging abnormalities (ARIA): radiological, biological and clinical characteristics","volume":"146","author":"Hampel","year":"2023","journal-title":"Brain"},{"key":"10.1016\/j.arr.2024.102203_bib14","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1126\/science.1566067","article-title":"Alzheimer's disease: the amyloid cascade hypothesis","volume":"256","author":"Hardy","year":"1992","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102203_bib15","unstructured":"Higgins, J., Thomas, J., Chandler, J., Cumpston, M., Li, T., Pag, M., Welch, V., 2022. Cochrane Handbook for Systematic Reviews of Interventions version 6.3 (Updated February 2022). \u3008www.training.cochrane.org\/handbook\u3009. 2022)."},{"key":"10.1016\/j.arr.2024.102203_bib16","unstructured":"Higgins, J., Thomas, J., Chandler, J., Cumpston, M., Li, T., Page, M., Welch, V., 2023. Cochrane Handbook for Systematic Reviews of Interventions version 6.4 (Updated August 2023). \u3008www.training.cochrane.org\/handbook\u3009. 2023)."},{"key":"10.1016\/j.arr.2024.102203_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.101996","article-title":"Passive Alzheimer's immunotherapy: a promising or uncertain option?","volume":"90","author":"Hoilund-Carlsen","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102203_bib18","doi-asserted-by":"crossref","DOI":"10.1186\/s12929-023-00976-6","article-title":"Clinical trials of new drugs for Alzheimer disease: a 2020-2023 update","volume":"30","author":"Huang","year":"2023","journal-title":"J. Biomed. Sci."},{"key":"10.1016\/j.arr.2024.102203_bib19","doi-asserted-by":"crossref","first-page":"777","DOI":"10.7326\/M14-2385","article-title":"The PRISMA extension statement for reporting of systematic reviews incorporating network meta-analyses of health care interventions: checklist and explanations","volume":"162","author":"Hutton","year":"2015","journal-title":"Ann. Intern Med"},{"key":"10.1016\/j.arr.2024.102203_bib20","unstructured":"Institute for Health Metrics and Evaluation, 2023. Grobal Health Data Exchange. \u3008https:\/\/vizhub.healthdata.org\/gbd-results\/\u3009 (Accessed 11.28 2023)."},{"key":"10.1016\/j.arr.2024.102203_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2023.102012","article-title":"Efficacy and safety of anti-amyloid-\u03b2 monoclonal antibodies in current Alzheimer's disease phase III clinical trials: a systematic review and interactive web app-based meta-analysis","volume":"90","author":"Jeremic","year":"2023","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102203_bib22","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jamapsychiatry.2017.2362","article-title":"Association of lithium in drinking water with the incidence of dementia","volume":"74","author":"Kessing","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/j.arr.2024.102203_bib23","doi-asserted-by":"crossref","first-page":"686","DOI":"10.14283\/jpad.2023.109","article-title":"Neuroinflammation, its role in Alzheimer's disease and therapeutic strategie","volume":"10","author":"Kiraly","year":"2023","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102203_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.redox.2023.102955","article-title":"Oxygen metabolism abnormality and Alzheimer's disease: an update","volume":"68","author":"Liu","year":"2023","journal-title":"Redox Biol."},{"key":"10.1016\/j.arr.2024.102203_bib25","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jad.2021.07.046","article-title":"Lithium effects on Hippocampus volumes in patients with bipolar disorder","volume":"294","author":"Lucini-Paioni","year":"2021","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.arr.2024.102203_bib26","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3233\/JAD-150437","article-title":"Lithium as a treatment for Alzheimer's disease: a systematic review and meta-analysis","volume":"48","author":"Matsunaga","year":"2015","journal-title":"J. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102203_bib27","doi-asserted-by":"crossref","first-page":"151","DOI":"10.14283\/jpad.2020.73","article-title":"Psychometric properties of the clinical dementia rating - sum of boxes and other cognitive and functional outcomes in a Prodromal Alzheimer's disease population","volume":"8","author":"McDougall","year":"2021","journal-title":"J. Prev. Alzheimers Dis."},{"key":"10.1016\/j.arr.2024.102203_bib28","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1056\/NEJMoa2100708","article-title":"Donanemab in early Alzheimer's disease","volume":"384","author":"Mintun","year":"2021","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.arr.2024.102203_bib29","first-page":"104","article-title":"Microdose lithium treatment stabilized cognitive impairment in patients with Alzheimer's disease","volume":"10","author":"Nunes","year":"2013","journal-title":"Curr. Alzheimer Res"},{"key":"10.1016\/j.arr.2024.102203_bib30","article-title":"CINeMA: Software for semiautomated assessment of the confidence in the results of network meta-analysis","volume":"16","author":"Papakonstantinou","year":"2020","journal-title":"Campbell Syst. Rev."},{"key":"10.1016\/j.arr.2024.102203_bib31","article-title":"Anti-amyloid antibody treatments for Alzheimer's disease","author":"Perneczky","year":"2023","journal-title":"Eur. J. Neurol."},{"key":"10.1016\/j.arr.2024.102203_bib32","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1126\/science.add9993","article-title":"Blots on a field?","volume":"377","author":"Piller","year":"2022","journal-title":"Science"},{"key":"10.1016\/j.arr.2024.102203_bib33","unstructured":"R Core Team, 2022. R: A Language and Environment for Statistical Computing. \u3008https:\/\/www.R-project.org\/\u3009 2022)."},{"key":"10.1016\/j.arr.2024.102203_bib34","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.jad.2005.01.002","article-title":"Effectiveness and medical costs of divalproex versus lithium in the treatment of bipolar disorder: results of a naturalistic clinical trial","volume":"86","author":"Revicki","year":"2005","journal-title":"J. Affect Disord."},{"key":"10.1016\/j.arr.2024.102203_bib35","unstructured":"R\u00fccker G., K.U., K\u00f6nig J., Efthimiou O., Davies A., Papakonstantinou T., Schwarzer G., 2022. netmeta: Network Meta-Analysis using Frequentist Methods_. R package version 2.5\u20130, \u3008https:\/\/CRAN.R-project.org\/package=netmeta\u3009 2022)."},{"key":"10.1016\/j.arr.2024.102203_bib36","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1001\/jama.2023.13239","article-title":"Donanemab in early symptomatic Alzheimer disease: the TRAILBLAZER-ALZ 2 randomized clinical trial","volume":"330","author":"Sims","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/j.arr.2024.102203_bib37","doi-asserted-by":"crossref","first-page":"501","DOI":"10.4103\/1673-5374.380898","article-title":"Targeting calcium signaling in Alzheimer's disease: challenges and promising therapeutic avenues","volume":"19","author":"Song","year":"2024","journal-title":"Neural Regen. Res"},{"key":"10.1016\/j.arr.2024.102203_bib38","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines11092331","article-title":"Current advances in mitochondrial targeted interventions in Alzheimer's disease","volume":"11","author":"Sousa","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/j.arr.2024.102203_bib39","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.arr.2024.102203_bib40","doi-asserted-by":"crossref","DOI":"10.1186\/s13195-021-00813-8","article-title":"A randomized, double-blind, phase 2b proof-of-concept clinical trial in early Alzheimer's disease with lecanemab, an anti-Abeta protofibril antibody","volume":"13","author":"Swanson","year":"2021","journal-title":"Alzheimers Res. Ther."},{"key":"10.1016\/j.arr.2024.102203_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.arr.2022.101709","article-title":"Comparative efficacy of lithium and aducanumab for cognitive decline in patients with mild cognitive impairment or Alzheimer's disease: a systematic review and network meta-analysis","volume":"81","author":"Terao","year":"2022","journal-title":"Ageing Res. Rev."},{"key":"10.1016\/j.arr.2024.102203_bib42","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1056\/NEJMoa2212948","article-title":"Lecanemab in early Alzheimer's disease","volume":"388","author":"van Dyck","year":"2023","journal-title":"N. Engl. J. Med"},{"key":"10.1016\/j.arr.2024.102203_bib43","article-title":"GLP-1\/Sigma\/RAGE receptors: an evolving picture of Alzheimer's disease pathology and treatment","author":"Wali","year":"2023","journal-title":"Ageing Res Rev."}],"container-title":["Ageing Research Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1568163724000217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T19:19:04Z","timestamp":1761592744000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1568163724000217"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2]]},"references-count":43,"alternative-id":["S1568163724000217"],"URL":"https:\/\/doi.org\/10.1016\/j.arr.2024.102203","relation":{},"ISSN":["1568-1637"],"issn-type":[{"value":"1568-1637","type":"print"}],"subject":[],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative efficacy, tolerability and acceptability of donanemab, lecanemab, aducanumab and lithium on cognitive function in mild cognitive impairment and Alzheimer's disease: A systematic review and network meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Ageing Research Reviews","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.arr.2024.102203","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"102203"}}